Phase
Alumni community member
in2cure
in2cure aims to develop novel treatments based on nature’s own defenses – evolutionary old biological systems which normally keep us healthy. It specializes in the development of proprietary peptide-based drugs for prevention and treatment of inflammatory diseases, infections, wound and surgical complications.
Helene holds a Master’s degree in Chemical Engineering from Lund Technical University. She is a strategic leader with 25 years’ experience in product, technology and business development. She as an extensive experience in driving change and reaching results by building bridges between stakeholders, often in complex intercultural environments.
Did you know?
in2cure’s product, BioC, is synthetically produced, but has a sequence identical to those fragments already present in the human body.
3D cell culture systems
Excellence in inhaler performance
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Unique stem cell therapeutics
Analysis services for drug development
Pest control solutions for bed bugs
GPS tracker system for elderly
Drug delivery platform
Excellence in designing & executing drug discovery
Models for autoimmune & inflammatory conditions
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Starch pickering emulsion technology
Customized in vitro and in vivo services
Regenerative medicine & cancer
